Last updated: October 10, 2022
Sponsor: Nanjing First Hospital, Nanjing Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Ulcers
Diabetes And Hypertension
Treatment
N/AClinical Study ID
NCT05577104
KY20220825-08
Ages 20-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with DFUs aged 20-80 years.
- Wagner grade 2 to 3.
- Chronic DFUs wounds (duration of disease ≥ 2 weeks).
- Ankle brachial ratio (ABI) 0.5~0.9, wound area 8~20 cm2.
Exclusion
Exclusion Criteria:
- Patients who were unable to complete the follow-up were not included,
- Pregnant or nursing mothers were not included.
- Patients with foot ulcers other than diabetes, peripheral vascular disease, organdysfunctions (heart failure, respiratory failure, liver dysfunction, renal impairmentor intestinal failure), or autoimmune diseases (rheumatoid arthritis, ankylosingspondylitis, systemic lupus erythematosus, Sjogren's syndrome, connective tissuesdisease or systemic vasculitis) were not included.
- Patients who received growth factors or hyperbaric oxygen therapies for the DFUswounds within one month were not included.
- Patients who had medications (such as corticosteroids, immunosuppressive agents orchemotherapy) within six months were not included.
Study Design
Total Participants: 40
Study Start date:
May 01, 2022
Estimated Completion Date:
December 10, 2022
Study Description
Connect with a study center
Nanjing First Hospital
Nanjing, Jiangsu 210029
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.